
VolitionRx Prepares Reimbursement Submission for Nu.Q Cancer Assays in France
VolitionRx is preparing a reimbursement submission for its Nu.Q Cancer assays in France, supported by Hospices Civils de Lyon, which could lead to routine clinical use for lung cancer management and broader commercialization.
Read full story

























